
Please try another search
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Eli Baker | 46 | 2020 | President, CFO, Secretary & Director |
Laurence E. Paul | 57 | 2021 | Independent Director |
Scott M. Delman | 61 | 2021 | Independent Director |
Dennis A. Miller | 64 | 2021 | Independent Director |
Joshua A. Kazam | 44 | 2021 | Independent Director |
Harry Evans Sloan | 71 | 2020 | CEO & Chairman |
Timothy Leiweke | 63 | 2021 | Independent Director |
Isaac Lee | 50 | 2021 | Independent Director |
Shyam Sankar | 42 | 2015 | Independent Chairman of the Board |
Paolo Martini | - | 2024 | Member of Biopharma Advisory Board |
Mark A. McCamish | 71 | 2024 | Member of Biopharma Advisory Board |
Harry Evans Sloan | 74 | 2021 | Independent Director |
Christi L. Shaw | 58 | 2024 | Member of Biopharma Advisory Board |
Ross Fubini | 48 | 2024 | Independent Director |
John M. Maraganore | 63 | 2024 | Member of Biopharma Advisory Board |
Norbert W. Bischofberger | 69 | 2024 | Member of Biopharma Advisory Board |
Sriram Kosuri | 45 | 2024 | Independent Director |
Jeff Legos | - | 2024 | Member of Biopharma Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review